EODData

NASDAQ, ROIV: Roivant Sciences Ltd

24 Apr 26 15:59
LAST:

27.39

CHANGE:
 0.73
OPEN:
28.14
HIGH:
28.32
ASK:
0.00
VOLUME:
3.35M
CHG(%):
2.59
PREV:
28.14
LOW:
27.06
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Apr 2628.2428.3227.0627.415.62M
23 Apr 2629.2529.4127.9228.147.6M
22 Apr 2629.5329.6429.0029.158.45M
21 Apr 2629.0329.3628.6729.292.95M
20 Apr 2629.7429.8828.9429.084.75M
17 Apr 2629.5430.1829.0029.836.5M
16 Apr 2629.6529.6528.9829.195.74M
15 Apr 2629.3229.4928.8629.393.53M
14 Apr 2629.0229.6928.9629.123.95M
13 Apr 2628.2129.1928.2128.953.36M

PROFILE

Name:Roivant Sciences Ltd
About:Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:11-12 St. James's Square, London, United Kingdom, SW1Y 4LB
Website:https://roivant.com
CUSIP:G76279101
CIK:0001635088
ISIN:BMG762791017
FIGI:BBG007STW2B8
LEI:549300DL466NY5J6U724

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:1.95 
Forward P/E:-26.93 
PEG Ratio:-0.01 
Price to Sales:587.56 
Price to Book:4.62 
Profit Margin:0.97 
Operating Margin:-128.40 
Return on Assets:-0.13 
Return on Equity:-0.18 
EPS Ratio:-1.17 
Revenue:23.23M 
Shares:715.7M 
Market Cap:19.603B 

TECHNICAL INDICATORS

MA5:28.614.5%
MA10:28.965.7%
MA20:28.343.5%
MA50:28.203.0%
MA100:25.288.3%
MA200:20.2135.5%
RSI14:46.08
WPR14:-100.00 
MTM14:-0.34
ROC14:-0.01 
ATR:0.88 
Week High:30.1810.2%
Week Low:27.061.2%
Month High:30.1810.2%
Month Low:25.9535.5%
Year High:30.3310.7%
Year Low:10.58158.9%
Volatility:5.87